| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 42 | +50.00% | +1.57% | +0.40% | +1.17% | -1.26% | 0.88 |
| 14d | 42 | +38.10% | +0.81% | -0.25% | +1.07% | +0.63% | 0.68 |
| 30d | 42 | +52.38% | +0.39% | +0.11% | +0.29% | -3.48% | 0.10 |
| 60d | 42 | +66.67% | -2.07% | +0.56% | -2.63% | -12.39% | -0.58 |
| 90d | 42 | +54.76% | +4.17% | +1.56% | +2.61% | -14.74% | 0.37 |
| 180d | 42(3 pending) | +69.23% | -8.27% | +8.48% | -16.76% | -36.84% | -2.12 |
| 1y | 42(3 pending) | +74.36% | -17.73% | +15.96% | -33.69% | -45.93% | -4.48 |
| 2y | 42(7 pending) | +77.14% | -26.80% | +38.70% | -65.50% | -84.35% | -7.02 |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 12,920 | — | — | 12,920 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,920 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 10,030 | — | — | 10,030 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 9,805 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 10,030 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 41,250 | — | — | 41,250 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 3,372 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 82,500 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 50,974 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 45,000 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,840 | — | — | 25,840 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 108,622 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 1,177,222 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 41,250 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 110,000 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 95,000 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 30,845 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 4,909 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 11,284 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 25,840 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 56,250 | — | — | 0 | May 14, 2026 | May 14, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,840 | — | — | 1,177,222 | Jan 28, 2026 | Jan 30, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 5,928 | $21.77 | $129.0K | 1,151,382 | Jan 22, 2026 | Jan 23, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 909 | $19.79 | $18.0K | 1,157,310 | Jan 20, 2026 | Jan 21, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 2,277 | $22.19 | $50.5K | 1,158,219 | Jan 13, 2026 | Jan 15, 2026 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 82,500 | $19.39 | $1.60M | 82,500 | Jun 9, 2025 | Jun 11, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 12,780 | $3.76 | $48.1K | 1,160,496 | May 21, 2025 | May 22, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,780 | — | — | 0 | May 21, 2025 | May 22, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 826 | $29.52 | $24.4K | 1,147,716 | Jan 29, 2025 | Jan 30, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 3,948 | $30.43 | $120.1K | 1,148,542 | Jan 22, 2025 | Jan 23, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 15,045 | — | — | 1,152,490 | Jan 21, 2025 | Jan 21, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 750 | $29.96 | $22.5K | 1,137,445 | Jan 17, 2025 | Jan 21, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 2,288 | $28.70 | $65.7K | 1,138,195 | Jan 13, 2025 | Jan 14, 2025 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 24,500 | — | — | 12,780 | May 20, 2024 | May 21, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 24,500 | $3.76 | $92.1K | 1,140,483 | May 20, 2024 | May 21, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 78,907 | — | — | 108,622 | May 8, 2024 | May 9, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 100 | $44.03 | $4.4K | 1,115,983 | May 8, 2024 | May 9, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 56,335 | $42.15 | $2.37M | 1,138,555 | May 8, 2024 | May 9, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 78,907 | $4.31 | $340.1K | 1,194,890 | May 8, 2024 | May 9, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 22,472 | $42.85 | $962.9K | 1,116,083 | May 8, 2024 | May 9, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 69,107 | — | — | 37,280 | Apr 8, 2024 | Apr 9, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 69,107 | $3.76 | $259.8K | 1,185,090 | Apr 8, 2024 | Apr 9, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 4,728 | $54.92 | $259.6K | 1,115,983 | Apr 8, 2024 | Apr 9, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 64,379 | $54.12 | $3.48M | 1,120,711 | Apr 8, 2024 | Apr 9, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 26,257 | $62.69 | $1.65M | 1,116,083 | Mar 8, 2024 | Mar 11, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 42,750 | $61.88 | $2.65M | 1,142,340 | Mar 8, 2024 | Mar 11, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 100 | $63.35 | $6.3K | 1,115,983 | Mar 8, 2024 | Mar 11, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 69,107 | $3.67 | $253.6K | 1,185,090 | Mar 8, 2024 | Mar 11, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 69,107 | — | — | 106,387 | Mar 8, 2024 | Mar 11, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 1,148 | $67.77 | $77.8K | 1,115,983 | Feb 12, 2024 | Feb 13, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 874 | $64.14 | $56.1K | 1,117,131 | Jan 29, 2024 | Jan 31, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 3,913 | $65.00 | $254.3K | 1,118,005 | Jan 22, 2024 | Jan 23, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 9,805 | $66.30 | $650.1K | 9,805 | Jan 16, 2024 | Jan 17, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 6,743 | — | — | 1,123,550 | Jan 16, 2024 | Jan 17, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 1,632 | $66.81 | $109.0K | 1,121,918 | Jan 16, 2024 | Jan 17, 2024 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 45,000 | $3.76 | $169.2K | 1,116,807 | Nov 14, 2023 | Nov 15, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 45,000 | — | — | 175,494 | Nov 14, 2023 | Nov 15, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 17,494 | — | — | 0 | Nov 8, 2023 | Nov 9, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 12,000 | $47.27 | $567.2K | 1,071,807 | Nov 8, 2023 | Nov 9, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 17,494 | $2.67 | $46.7K | 1,083,807 | Nov 8, 2023 | Nov 9, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 1,078,313 | Oct 9, 2023 | Oct 10, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 17,494 | Oct 9, 2023 | Oct 10, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 12,000 | $40.38 | $484.6K | 1,066,313 | Oct 9, 2023 | Oct 10, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 1,071,813 | Sep 8, 2023 | Sep 11, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 35,994 | Sep 8, 2023 | Sep 11, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 12,000 | $42.87 | $514.4K | 1,059,813 | Sep 8, 2023 | Sep 11, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 1,065,313 | Aug 8, 2023 | Aug 9, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 12,000 | $23.66 | $283.9K | 1,053,313 | Aug 8, 2023 | Aug 9, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 54,494 | Aug 8, 2023 | Aug 9, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 91,494 | Jun 8, 2023 | Jun 9, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 12,000 | $91.35 | $1.10M | 1,040,313 | Jun 8, 2023 | Jun 9, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 1,052,313 | Jun 8, 2023 | Jun 9, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 1,045,813 | May 8, 2023 | May 9, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 12,000 | $92.39 | $1.11M | 1,033,813 | May 8, 2023 | May 9, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 109,994 | May 8, 2023 | May 9, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 128,494 | Apr 10, 2023 | Apr 11, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 1,039,313 | Apr 10, 2023 | Apr 11, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 12,000 | $78.21 | $938.5K | 1,027,313 | Apr 10, 2023 | Apr 11, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 1,032,813 | Mar 8, 2023 | Mar 10, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 146,994 | Mar 8, 2023 | Mar 10, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,000 | $63.79 | $765.5K | 1,020,813 | Mar 8, 2023 | Mar 10, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 14,023 | — | — | 14,023 | Feb 21, 2023 | Feb 21, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 9,886 | — | — | 1,015,508 | Feb 21, 2023 | Feb 21, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 1,195 | $58.50 | $69.9K | 1,014,313 | Feb 21, 2023 | Feb 21, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 1,134 | $51.21 | $58.1K | 1,005,622 | Feb 10, 2023 | Feb 14, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 165,494 | Feb 8, 2023 | Feb 10, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 1,018,756 | Feb 8, 2023 | Feb 10, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,000 | $54.45 | $653.4K | 1,006,756 | Feb 8, 2023 | Feb 10, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 832 | $52.77 | $43.9K | 1,000,256 | Jan 27, 2023 | Jan 30, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 2,326 | $52.05 | $121.1K | 1,001,088 | Jan 20, 2023 | Jan 24, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 30,845 | $52.66 | $1.62M | 30,845 | Jan 12, 2023 | Jan 17, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 19,634 | — | — | 1,003,414 | Jan 12, 2023 | Jan 17, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,000 | $46.08 | $553.0K | 983,780 | Jan 9, 2023 | Jan 10, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 183,994 | Jan 9, 2023 | Jan 10, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 995,780 | Jan 9, 2023 | Jan 10, 2023 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 7,000 | — | — | 220,494 | Dec 29, 2022 | Dec 30, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 7,000 | $3.67 | $25.7K | 977,280 | Dec 29, 2022 | Dec 30, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 202,494 | Dec 8, 2022 | Dec 12, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 982,280 | Dec 8, 2022 | Dec 12, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,000 | $47.50 | $570.0K | 970,280 | Dec 8, 2022 | Dec 12, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 975,780 | Nov 8, 2022 | Nov 10, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 220,994 | Nov 8, 2022 | Nov 10, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,000 | $46.47 | $557.6K | 963,780 | Nov 8, 2022 | Nov 10, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,000 | $57.50 | $690.0K | 957,280 | Oct 10, 2022 | Oct 11, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 969,280 | Oct 10, 2022 | Oct 11, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 239,494 | Oct 10, 2022 | Oct 11, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 962,780 | Sep 8, 2022 | Sep 12, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,000 | $63.98 | $767.8K | 950,780 | Sep 8, 2022 | Sep 12, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 257,994 | Sep 8, 2022 | Sep 12, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,000 | $62.50 | $750.0K | 944,280 | Aug 8, 2022 | Aug 9, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 18,500 | $2.67 | $49.4K | 956,280 | Aug 8, 2022 | Aug 9, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 18,500 | — | — | 276,494 | Aug 8, 2022 | Aug 9, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 6,500 | $2.67 | $17.4K | 949,780 | Jul 8, 2022 | Jul 11, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 6,500 | — | — | 294,994 | Jul 8, 2022 | Jul 11, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,000 | $47.95 | $575.4K | 937,780 | Jul 8, 2022 | Jul 11, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,000 | — | — | 301,494 | Jul 8, 2022 | Jul 11, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 12,000 | $2.67 | $32.0K | 943,280 | Jul 8, 2022 | Jul 11, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 33,005 | $2.67 | $88.1K | 931,280 | Jun 17, 2022 | Jun 22, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 33,005 | — | — | 313,494 | Jun 17, 2022 | Jun 22, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 6,500 | $2.67 | $17.4K | 898,275 | Jun 8, 2022 | Jun 9, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 6,500 | — | — | 346,499 | Jun 8, 2022 | Jun 9, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 12,000 | $2.67 | $32.0K | 903,775 | Jun 8, 2022 | Jun 9, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,000 | $44.09 | $529.1K | 891,775 | Jun 8, 2022 | Jun 9, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 12,000 | — | — | 352,999 | Jun 8, 2022 | Jun 9, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 4,000 | — | — | 364,999 | Apr 29, 2022 | May 2, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 4,000 | $44.43 | $177.7K | 891,775 | Apr 29, 2022 | May 2, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 4,000 | $2.67 | $10.7K | 895,775 | Apr 29, 2022 | May 2, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 1,875 | — | — | 891,775 | Apr 21, 2022 | May 2, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 11,250 | — | — | 0 | Apr 21, 2022 | May 2, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 1,057 | $47.12 | $49.8K | 893,650 | Feb 10, 2022 | Feb 11, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 931 | $38.59 | $35.9K | 894,707 | Jan 28, 2022 | Jan 31, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 26,051 | — | — | 895,638 | Jan 21, 2022 | Jan 25, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 36,951 | — | — | 36,951 | Jan 21, 2022 | Jan 25, 2022 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 6,250 | — | — | 368,999 | Jun 24, 2021 | Jun 25, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 6,250 | $2.67 | $16.7K | 875,837 | Jun 24, 2021 | Jun 25, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 6,250 | $65.61 | $410.1K | 869,587 | Jun 24, 2021 | Jun 25, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 6,250 | $47.40 | $296.3K | 869,587 | May 24, 2021 | May 25, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 6,250 | $2.67 | $16.7K | 875,837 | May 24, 2021 | May 25, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 6,250 | — | — | 375,249 | May 24, 2021 | May 25, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 4,500 | — | — | 381,499 | Apr 28, 2021 | Apr 28, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 4,500 | $2.67 | $12.0K | 869,587 | Apr 28, 2021 | Apr 28, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 6,250 | — | — | 385,999 | Apr 23, 2021 | Apr 26, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 6,250 | $2.67 | $16.7K | 871,337 | Apr 23, 2021 | Apr 26, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 6,250 | $46.13 | $288.3K | 865,087 | Apr 23, 2021 | Apr 26, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 6,250 | $50.74 | $317.1K | 865,087 | Mar 10, 2021 | Mar 11, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Scientific Officer | 6,250 | $2.67 | $16.7K | 871,337 | Mar 10, 2021 | Mar 11, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 6,250 | — | — | 392,249 | Mar 10, 2021 | Mar 11, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Scientific Officer | 688 | $47.72 | $32.8K | 865,087 | Feb 10, 2021 | Feb 11, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 45,000 | — | — | 45,000 | Jan 28, 2021 | Feb 1, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 11,250 | — | — | 11,250 | Jan 28, 2021 | Feb 1, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 7,500 | — | — | 863,900 | Jan 28, 2021 | Feb 1, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 1,875 | — | — | 865,775 | Jan 28, 2021 | Feb 1, 2021 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALEGRANT Gift | 161,656 | — | — | 847,025 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 55,398 | $40.98 | $2.27M | 1,008,681 | Feb 13, 2020 | Feb 14, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 117,205 | — | — | 0 | Feb 13, 2020 | Feb 14, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Operating Officer | 117,205 | $2.14 | $250.8K | 1,064,079 | Feb 13, 2020 | Feb 14, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASE Chief Operating Officer | 117,206 | $2.14 | $250.8K | 998,949 | Feb 12, 2020 | Feb 14, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 117,206 | — | — | 117,205 | Feb 12, 2020 | Feb 14, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 52,075 | $42.80 | $2.23M | 946,874 | Feb 12, 2020 | Feb 14, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 9,375 | — | — | 891,118 | Feb 10, 2020 | Feb 12, 2020 ↗ | View → |
| APLS APELLIS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 56,250 | — | — | 56,250 | Feb 10, 2020 | Feb 12, 2020 ↗ | View → |